课题基金 / 基金详情

Analysis of cell adhesion and polarity formation by a novel tumor suppressor protein TSLC1 and its related molecules

Analysis of cell adhesion and polarity formation by a novel tumor suppressor protein TSLC1 and its related molecules
新型抑癌蛋白TSLC1及其相关分子对细胞粘附和极性形成的分析
批准号:
15590262
负责人:
MURAKAMI Yoshinori
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MURAKAMI Yoshinori的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Morphological transformation is a fundamental feature of malignant cancer cells. The tumor suppressor, TSLC1/IGSF4, is involved in cell adhesion and preferentially inactivated in invasive cancer. We have previously shown that TSLC1 associates with an actin-binding protein, DAL-1/4.1B, and a scaffold protein, membrane protein palmitoylated 3(MPP3). Here, we identified MPP1/p55 and MPP2/DLG2 as additional cytoplasmic proteins binding to TSLC1 and investigated the roles of the TSLC1 cascade in epithelial cell morphology and its malignant transformation. MPP1, MPP2, and MPP3 interacted directly with DAL-1, forming a tripartite complex with TSLC1. Whereas these complexes localized along the cell membranes in confluent HEK293 cells, only MPP2, but not MPP1 or MPP3, was recruited to the TSLC1-DAL-1 complex in the early process of cell adhesion. When the TSLC1 function was abrogated by RNAi, HEK293 losed epithelial-like structure and showed flat morphology with immature cell adhesion. Furthermore, DAL-1 and MPP2, as well as E-cadherin and ZO-1, were mislocalized from the membrane. Loss of TSLC1 was also correlated with the transformed phenotype of lung cancer cells. These findings suggest that TSLC1 is involved in the formation of epithelial-like cell structure with DAL-1 and MPPs, while loss of its function could cause morphological transformation of cancer cells.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
Ito, T., Shimada, Y., Murakami, Y., Imamura, M.et al.: "Involvement of TSLC1 in progression of esophageal squamous cell carcinoma."Cancer Research. 63. 6320-6326 (2003)
Ito, T.、Shimada, Y.、Murakami, Y.、Imamura, M.等人:“TSLC1 参与食管鳞状细胞癌的进展。”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.3892/or.12.1.47
发表时间: 2004-07
期刊: Oncology reports
影响因子: 4.2
作者: [M. Saino;T. Maruyama;T. Sekiya;T. Kayama;Y. Murakami]
通讯作者: M. Saino;T. Maruyama;T. Sekiya;T. Kayama;Y. Murakami
DOI: 10.1038/sj.onc.1206744
发表时间: 2003-09-18
期刊: ONCOGENE
影响因子: 8
作者: [Fukuhara, H, Masvuda, M, Murakami, Y]
通讯作者: Murakami, Y
The cytoplasmic domain is critical to the tumour suppressor activity of TSLC1 in non-small cell lung cancer.
胞质结构域对于 TSLC1 在非小细胞肺癌中的肿瘤抑制活性至关重要。
DOI: --
发表时间: 2003
期刊: Cancer Res. 63
影响因子: --
作者: [Mao, X., Seidlitz, E., Ghosh, K., Murakami, Y., Ghosh, H.P.]
通讯作者: H.P.
16
    Platform of Supporting Cohort Study and Biospecimen Analysis
    • 批准号:
      16H06277
    • 项目类别:
      Grant-in-Aid for Scientific Research on Innovative Areas ― Platforms for Advanced Technologies and Research Resources
    • 资助金额:
      $1456.67万
    • 财政年份:
      2016
    • 负责人:
      MURAKAMI Yoshinori
    • 依托单位:
    Analysis of somatic alteration of copy number variation in cancer as a new instability of cancer
    • 批准号:
      26640121
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.0万
    • 财政年份:
      2014
    • 负责人:
      MURAKAMI Yoshinori
    • 依托单位:
    Analysis of cell-context dependent features of adhesion molecules for cancer diagnosis
    • 批准号:
      25290051
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.82万
    • 财政年份:
      2013
    • 负责人:
      MURAKAMI Yoshinori
    • 依托单位:
    Usage of teaching materials and to develop teaching materials in the field of special needs education
    • 批准号:
      23653310
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.91万
    • 财政年份:
      2011
    • 负责人:
      MURAKAMI Yoshinori
    • 依托单位: